Pennsylvania Recovery and Resiliency - Behavioral Health for the New Century

Adult and Juvenile Justice Alternatives to Seclusion and
Restraint Community Integration Co-occurring Mental
Health/Addiction Early Childhood Mental Health Mobile Mental Health Other OMHSAS Initiatives Peer Specialist Services Psychiatric Rehabilitation School Based Mental Health Suicide Prevention Supportive Employment Supportive Housing Transition Age Youth Youth/Family Teams

OMHSAS Mission/Vision/
Guiding Principles Community Support Program Child and Adolescent
Service System Program (CASSP) "A Call for Change" BDAP D&A Principles Cultural Competency

Accessing County-Based Services DPW Bulletins Conferences and Trainings Glossary Newsletters/Publications DPW Web Site

Statewide Associations National Groups

Advisory Structure Contact Information Objectives/Priorities OMHSAS 2008/09 Budget Quality Improvement Efforts

What's New > Adult Services

Special Pharmaceutical Benefits Program Available

The Office of Mental Health and Substance Abuse Services (OMHSAS) wants qualified persons to be aware and make use of the Special Pharmaceutical Benefits Program (SPBP) for Mental Health. SPBP funds are available to assist persons with a diagnosis of schizophrenia with certain medications for individuals who are not eligible for Medical Assistance and have income of $30,000 or less. Covered medications include Abilify, Clozaril, Clozapine, Geodon, Risperdal, Seroquel, and Zyprexa. SPBP can pay Medicare premiums, co-payments, and deductibles for these covered medications. Benefits can usually be available within one week of receiving a completed application. The application form and additional materials are available on the SPBP web site at www.dpw.state.pa.us/PartnersProviders/MedicalAssistance/AdvocatesStakeholders/AIDSClozarilProgram. Applicants can call 877-356-5355 for assistance with completing the application form.